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p-GLUCANS MODULATE ALVEOLAR MACROPHAGE 
RESPONSE TO BACTERIAL LIPOPOLYSACCHARIDE. OA
Hoffman, TE Standing, AH Limper. Thoracic Disease Research Unit, 
Mayo Clinic and Foundation, Rochester MN.
Tumor necrosis factor-alpha (TNFa) is a potent proinflammatory 
cytokine believed to play a central role in the pathogenesis of 
endotoxin-induced shock and the adult respiratory distress syndrome. 
Pretreatment of animals with p-glucan prior to bacterial challenge 
reduces detectable TNFa and lethal infection (J. Cell. Biochem., 1991; 
46: 60). We therefore hypothesized that p-glucan might directly 
regulate TNFa secretion from alveolar macrophages (AMS) in 
response to lipopolysaccharide (LPS). Rat AMS were cultured in the 
presence of increasing concentrations of p-glucan alone and TNFa 
secretion quantified using a sensitive L929 cytotoxicity assay. 
Whereas unstimulated AMS released 22.7± 5.3 pg/m l of TNFa, 
addition of p-glucan at doses of 10 and 100 |ig/m l resulted in 
increased TNFa release (113.1 ± 26.1 and 729.9 ± 294.3 pg/m l TNFa 
respectively; p<0.05 compared to control). However, larger 
concentration of p-glucan (>500ng/ml) resulted in suppression of 
TNFa release from AMS (15.0± 1.6 pg/ml; p=NS compared to 
controls). Furthermore, preincubation of AMS with 500 jig/ml of (i- 
glucan also inhibited the secretion of TNFa induced by LPS (10 
p.g/ml). Whereas LPS-stimulated AMS released 13/407±248 pg/m l of 
TNFa, AMS pretreated with p-glucan released only 4.0+0.2 pg/ml. 
Additionally, interferon-gamma (IFN) (lOng/ml), a potent activator of 
TNFa expression, failed to overcome the inhibition of TNFa release 
induced by p-glucan. Our study demonstrates that p-glucan regulates 
the secretion of TNFa from AMS. Lower concentrations p-glucan itself 
stimulate TNFa release, however higher concentrations of p-glucan 
inhibit TNFa secretion. Furthermore, AMS suppressed by p-glucan 
are also refractory to further stimulation by LPS even following IFN 
priming. These data suggest an immunomodulatory role of p-glucan 
which may explain its beneficial effect in models of sepsis.
TGF-/3 AND TNF-a INFLUENCE FIBRIN TURNOVER IN HUMAN 
TRACHEAL EPITHELIAL CELLS IN VITRO. Johnson^ AR. 
Koenia, KB. and Idell. S> University of Texas Health 
Cntr,Tyler, TX, USA.
Alveolar fibrin deposition characterizes alveolitis 
of severe forms of lung injury and may potentiate 
inflammation and subsequent alveolar organization. The 
epithelial lining of small airways and alveoli can 
influence local fibrin deposition via expression of 
procoagulant and fibrinolytic proteins. We used a 
human tracheal epithelial cell line (HEPC) to study 
cytokine influence on fibrin deposition. From recal­
cification times in factor-deficient plasmas we found 
that tissue factor (TF) accounts for most procoagulant 
activity of HEPC and confirmed this by direct and 
indirect binding studies with factor VII and neutral­
ization with TF antibody. TGF-/3 and TNF-a stimulated 
release of TF into HEPC-conditioned media, HEPC 
expressed plasminogen-dependent fibrinolytic activity 
which, by fibrin enzymography, was primarily uFA; some 
remained in complex with inhibitor (s) . TGF-/3 and TNF-a 
altered expression of fibrinolytic proteins and 
inhibitors in HEPC as measured by fibrin radio-assay 
and ELISAs. TGF-0 depressed fibrinolytic activity in 
both cells and media. By contrast, TNF-a increased 
both cell-associated and media fibrinolytic activity. 
TNF-a also induced increased expression of uPA and tPA 
in HPEC, whereas TGF-/3 did not. TGF-/3 enhanced both 
cell-associated and media PAI-1, but TNF-a caused only 
a slight increase in released PAI-1. PAI-l induction 
by cytokines was confirmed by reverse fibrin enzymo­
graphy. The disparate fibrinolytic response of HEPC to 
TGF-J0 and TNF-a differs from other human lung cells 
(mésothélium and fibroblasts) we studied previously. 
Although induction of procoagulant activity and 
depression of fibrinolysis by TGF-0 favors fibrin 
deposition, induction of fibrinolytic activity by TNF- 
a could shift the balance towards fibrin clearance.
Supported by NIH grants HL45018, HL37770 and HL44473.
POTENTIAL, INDIRECT ANTI-INFLAMMATORY EFFECTS OF IL-4: 
STIMULATION OF HUMAN MONOCYTES, MACROPHAGES, AND 
ENDOTHELIAL CELLS BY IL-4 INCREASES AMINOPEPTIDASE-N-ACTIVITY
(CD 13; EC 3.4.11.2)
P.Th.W. van Hal1, J.P.M. Hopstaken-Broos1, A. Prins1, H.C. Hoogsteden2,
R.J.F. Huljbens , C.G. Figdor3, and C. Hilvering2 
Depts. of Immunology1 and Pulmonary Medicine2, Erasmus University and 
University Hospital Dijkzigt, Rotterdam; Dept, of Immunology3, Antoni van
Leeuwenhoek Huis, Amsterdam, The Netherlands.
IL-4 up-regulates various monocytic properties, which are associated with pro- 
inflammatory functions. Paradoxically, IL-4 may also act as an anti-inflammatory 
agent by down-reguiating the production of several Inflammatory mediators. Studies 
have already been started to examine these properties in v/vo. As the activity of 
some mediators has recently been shown to be regulated by peptidases, we 
examined whether IL-4 was able to modulate the expression of a cell membrane 
associated peptidase, amlnopeptidase-N (CD13),
Monocytes were isolated from healthy volunteers, purified by centrifugal 
élutriation, and cultured under non-adherent conditions in Teflon bags. Expression 
of cell surface antigens was analysed with a FACScan, IL-4 caused a dose- 
dependent Increase of the expression of CD13 Ag on these cells. Maximai 
expression was observed around 48 h of culture. This IL-4-induced Increase was 
completely blocked by anti-lL-4 antiserum. Furthermore, the increase In surface 
expression was preceded by increased mRNA levels of CD13, which was maximal 
around 24 hours of culture. We also observed that CD13-mediated leucine- 
aminopeptldase activity of monocytes was induced by IL-4. Also other CD13- 
expressing cells were sensitive to IL-4, since CD13 Ag expression and CD13 mRNA 
levels were up-regulated In human alveolar macrophages and endothelial cells upon 
IL-4 treatment.
The Increased expression of cell membrane aminopeptIdase»N represents a 
potentially increased cellular ability to inactivate inflammatory mediators. Therefore, 
these findings represent further evidence of lL-4-mediated anti-inflammatory actions. 
We postulate that up-regulation of aminopeptidase-N expression may be an Indirect 
working-mechanlsm of IL-4 to modulate the action of bioactive peptides. This 
mechanism as such may also be relevant in studies on the anti-inflammatory effects 
or IL-4 in vivo.
Supported by Glaxo Holland b.v.
MODULATION BY IL -1 0 ,  ll-b and TGF3 OF TNFa, TNF3 AND T CELL 
PROLIFERATION INDUCED BY .ALLOGENIC ALVEOLAR MACROPHAGES OR 
DENDRITIC CELLS.
L .P . N ico d * ,  F . E l H abre, J .-M . P ayer
D iv is io n  o f  R e s p ira to ry  D iseases* and D iv is io n  o f  Im m unology 
and A l le r g y ,  U n iv e r s i t y  H o s p ita l,  Geneva, S w itz e r la n d .
TNFa and TNF$ a re  p o w e rfu l in f la m m a to ry  and c y to to x ic  c y to k in e s  
th a t  may p la y  a key r o le  in  acu te  o r  c h ro n ic  lu n g  r e je c t io n .  We 
have s tu d ie d  t h e i r  re le a s e  d u r in g  a l lo g e n ic  re a c t io n s  in d u ce d  
by e i t h e r  human lu n g  d e n d r it ic  c e l ls  (DC) o r  a lv e o la r  macropha­
ges (AM). The m o d u la tio n  o f  t h e i r  p ro d u c t io n  by IL -1 0 ,  IL -U  o r 
TGFB was a n a ly z e d . DC were sepa ra ted  u s in g  t h e i r  d e n s i ty ,  t h e i r  
lo o s e  adherence and t h e i r  absence o f  au to  f lu o r é s  ce n t p h a g o c y tic  
in c lu s io n s .  AM o r  DC ( 2 0 x 1 0 ^) o b ta in e d  from  th e  same s u r g ic a l  
specimens were m ixed w ith  a l lo g e n ic  T C e lls  ( 1 5 0 x 1 0 ^ ) .  S upe r- 
n a ta n ts  were c o l le c te d  d u rin g  f iv e  c o n s e c u tiv e  days . The 
m axim al c o n c e n tra t io n  o f  TNFa and 3 vas measured th e  f i f t h  day 
by RIA (M edgen ix) and ELISA (R and D ) , r e s p e c t iv e ly .  TNFa 
le v e ls  were 169^ 133 pg/m l SEM) and 513 _+ 6b p g /m l when 
T C e lls  were m ixed w ith  DC and AM (n  = 6 ) ,  r e s p e c t iv e ly .  The 
TNF0 le v e ls  were 7 8 6  _+ 1 8 7  p g /m l w ith  DC-T C e lls  and 100 _+ 57 
w ith  AM-T C e l ls .  When IL -1 0 , IL -h  o r  TGF(3 was added t o  th e  
a l lo r e a c t io n s  o n ly  IL -1 0  ( I0 n g /m l)  reduced  T c e l l  p r o l i f e r a t i o n  
(e xp re sse d  in  cpm) as w e ll as TNFa o r  3  as shown h e re  in  a 
re p re s e n ta t iv e  e xp e rim e n t;
DC + T DC + T + IL -1 0  AM + T AM + T + IL -1 0
cpm 1+3.2Û1
TNFa (p g /m l)  2.25U
TNF3 (p g /m l)  3^9
25-502
J6 0
56
13.156
500
<15
3 .7 99  
278 
<15
W ith  IL -U  T c e l l  p r o l i f e r a t io n  as w e l l  as TNFfi p ro d u c t io n  were 
enhanced by 6 0  +_ 1 6 % and 2 7 5  ±  2 2 % r e s p e c t iv e ly  in  th e  
presence o f  DC whereas TNFa c o n c e n tra t io n s  were n o t s ig n i f i c a n ­
t l y  changed. W ith  TGFB T c e l l  p r o l i f e r a t i o n  and TNFa p ro d u c t io n  
were s l i g h t l y  decreased  by 39 ±  11$ and 2 8  ±  35$ r e s p e c t iv e ly ,  
whereas TNF$ was in c re a se d  by 9 5  _+ 27$* Thus IL - 1 0 ,  c o n t r a r i l y  
t o  IL - h  o r  TGF3 p ro d u c t io n  decreased T c e l l  p r o l i f e r a t i o n  as 
w e l l  as TNFa o r  TNF3 d u rin g  a l lo g e n ic  r e a c t io n .
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